Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
108.13
(
2.89%
)
Bitcoin
67,838.00
(
0.00%
)
News Focus
News Focus
Post# of 19309
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122806
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: mblimon post# 783

Thursday, 09/14/2006 6:04:21 AM

Thursday, September 14, 2006 6:04:21 AM

Post# of 19309
>My question is whether a clinical center is allowed to do such experiments without an officially accepted protocol (by the EMEA) or whether existing approvals for plasma ATiii indications allow these experiments, because they are very similar to what has been done.<

The former—i.e. this is an off-label use of AT.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today